Skip to main content
. 2013 Feb 5;31(4):769–777. doi: 10.3892/ijmm.2013.1269

Figure 4.

Figure 4

Suppressive effects of IL-17 on the late phase of osteoclastogenesis. (A) IL-17 exhibited different effects on osteoclastogenesis in the ‘early’ phase of osteoclastogenesis at the given concentrations. (B) IL-17 yielded suppressive effects on osteoclastogenesis at all concentrations (from 0.1 to 10 ng/ml) in the ‘late’ phase of osteoclastogenesis. Values are the means ± SD of 3 independent experiments. #P<0.05 and *P<0.001 compared with Nil. Nil, control group.